PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
DNA Repair (Amst). Author manuscript; available in PMC 2009 August 25.
Published in final edited form as:
PMCID: PMC2731414
NIHMSID: NIHMS41898

DNA repair is crucial for maintaining hematopoietic stem cell function

Abstract

Richard Cornall and collaborators recently developed a mouse model of Ligase IV syndrome with growth retardation and immunodeficiency due to a defect in nonhomologous end-joining (NHEJ) of DNA double-strand breaks. They demonstrated age-dependent loss of hematopoietic stem cell function in these mice. Simultaneously, Irving Weissman and colleagues demonstrated a similar phenomenon in Ku80−/− mice defective in NHEJ and telomere maintenance, XpdTTD mice defective in nucleotide excision repair, and late generation mTr−/− missing telomerase activity. These studies strongly support the hypothesis that genomic stress causes aging by limiting the ability of stem cells to indefinitely maintain tissue homeostasis.

Keywords: aging, progeria, oxidative stress, endogenous damage

A topic of keen interest in the field of genome maintenance is whether distinct cell types have different capacities for DNA repair and therefore sensitivity to genotoxic stress [1, 2]. Tissue-specific stem cells are of particular interest [3, 4] since these cells are responsible for organ development, sustaining tissue homeostasis and tissue regeneration after injury [5]. Maintaining stem cells throughout the entire lifespan of an organism is essential for preserving both tissue function and the ability of that organ to respond to stress [6]. Aging itself is defined as the loss of homeostatic reserve [7]. Thus loss of tissue-specific stem cells is predicted to promote aging [8, 9].

Tissue-specific stem cells are also implicated in carcinogenesis. Stem cells have several unique characteristics that make them a logical nidus for cancer. They are long-lived, increasing the odds that a single cell could acquire the multiple mutations necessary for transformation. Stem cells also have an unlimited capacity for cell division and an ability to spawn multiple cell types, characteristics shared with tumors [10]. Furthermore, the quiescent nature of stem cells renders them resistant to chemotherapy [11] and therefore a potential source of tumor recurrence. Thus, determining how stem cells respond to genotoxic stress is critical for understanding the fundamental mechanisms of aging and cancer.

Two recent manuscripts provide great inroads into revealing how stem cells respond to DNA damage through the study of hematopoietic stem cells (HSCs) in DNA repair deficient mice [12, 13]. Nijnik et al. examined HSC number and function in Lig4-deficient mice (Lig4Y288C), defective in non-homologous end-joining (NHEJ) repair of DNA double-strand breaks (DSBs). Rossi et al. did similar experiments using three mouse models of accelerated aging: XpdTTD mice, defective in nucleotide excision repair of helix-distorting DNA lesions [14], Ku80−/− mice defective in NHEJ of DSBs and telomere maintenance [15, 16], and mTR−/− mice missing telomerase activity [17]. In all cases, HSCs from these DNA repair-deficient mice were compromised prematurely relative to normal mice, demonstrating that three major genome protection mechanisms are required for maintenance of stem cells, at least in the hematopoietic system. The major implication is that stem cells are vulnerable to endogenous DNA damage and that failure to repair this damage limits stem cell function.

Mammalian hematopoiesis

Hematopoiesis in adult mammals occurs in the bone marrow (BM). Replacement of both myeloid (granulocytes, monocytes, platelets, red blood cells) and lymphoid (B, T and natural killer cells) lineages is dependent upon long-term reconstituting hematopoietic stem cells (LT-HSCs). LT-HSCs can be isolated from the BM based on their unique pattern of surface markers (lineage, c-Kit+, Sca-1+, flk2/CD135, CD34). The definition of stem cells encompasses a functional component (Figure 1). All stem cells have the unique capacity to divide to produce a phenocopy of themselves (self-renewal) and a more differentiated cell, which in the BM is the short-term reconstituting HSC (ST-HSC; lineage, c-Kit+, Sca-1+, flk2/CD135, CD34+). ST-HSCs give rise to more committed multi-potent progenitor cells (MPP; lineage, c-Kit+, Sca-1+, flk2/CD135+, CD34+), which in turn give rise to the common lymphoid progenitors (CLPs) that produce lymphoid lineages and the common myeloid progenitors (CMPs) that produce myeloid lineages. The extent of lineage commitment parallels proliferation rate, meaning that the pluripotent LT-HSCs are relatively quiescent compared to the more committed progenitors.

Figure 1
Schematic diagram of the linear hierarchy of hematopoietic cells. Cell surface markers used to identify each cell population are indicated with colored bars. Checked bars indicate surface markers with low expression. The blue color of the nuclei indicates ...

DNA repair is not required to maintain hematopoietic stem cell number

To quantify HSCs, both groups measured the percent of BM cells with LT-HSC-specific surface markers in normal and DNA repair deficient mice at various ages using flow cytometry (Table I). There is a marked decrease in BM cellularity and the MPP compartment as early as 7 weeks of age in Lig4-deficient mice relative to age-matched controls [12]. However, the LT-HSCs and ST-HSCs are conserved in mice as old as 6 months of age. Similarly, the fraction of LT-HSCs and ST-HSCs in XpdTTD and third generation mTR−/− mice (with shortened telomeres) is conserved up to ~1 year of age and in Ku80−/− mice for at least 30 weeks [13]. In fact, the frequency of LT-HSCs increased significantly with age in each of these progeroid mouse models, identical to what is observed in wild type mice [13]. However, like the Lig4-deficient mice, the fraction of progenitor cells is significantly reduced in all three progeroid mouse strains relative to controls, even in young adult mice [13]. This demonstrates that defects in multiple mechanisms required for genome stability (nucleotide excision repair, NHEJ and telomere maintenance) are not essential for establishing or maintaining the relatively quiescent LT-HSCs. However, maintenance of the more proliferative progenitor lineages is dependent on these DNA repair mechanisms.

Table I
Comparison of the hematopoietic defects in mouse models of genome instability disorders.

DNA repair is required to maintain hematopoietic stem cell function

To measure the function of HSCs, LT-HSCs were isolated from DNA repair-deficient mice at various ages and used to competitively transplant lethally irradiated mice. Fifty LT-HSCs from a DNA repair-deficient mouse were combined with 2×105 BM cells from a control animal to determine if the stem cells could reconstitute the BM of the irradiated host. Read-outs included measuring the fraction of lymphocytes and myeloid cells in the peripheral blood of the irradiated host at various time points post-transplantation to determine the short- and long-term reconstituting capacity of the HSCs. Circulating cells derived from LT-HSCs are distinguished using a strain-specific marker on the surface of the white blood cells (CD45.2 vs. CD45.1 for cells derived from the competitor BM or irradiated host).

The fraction of myeloid and lymphoid cells derived from LT-HSCs isolated from progeroid XpdTTD, mTR−/− and Ku80−/− mice was significantly decreased compared to transplants from age-matched wild type mice [13]. Granulocytes turn-over rapidly. Thus measuring the fraction of granulocytes stemming from LT-HSCs transplanted into an irradiated host (granulocyte chimerism) offers a near real-time assessment of HSC function. The fraction of granulocytes derived from adult XpdTTD, mTR−/−, Ku80−/− and Lig4Y288C mouse LT-HSCs was significantly lower than wild type controls and continued to decrease with time post-transplantation, demonstrating exhaustion of HSC function when genome maintenance is compromised [12, 13]. Importantly, the dramatic difference in granulocyte chimerism afforded by transplantation of wild type or DNA repair deficient LT-HSCs is not observed if younger donors are used [13]. Thus while LT-HSC numbers are conserved with ageing in XpdTTD, mTR−/−, Ku80−/− and Lig4Y288C mice with defective genome maintenance, HSC function is lost prematurely in a cell autonomous fashion. This suggests that loss of hematopoietic reserves is caused by the accumulation of DNA damage in HSCs.

Loss of stem cell function is due to impaired self-renewal

Accumulation of DNA damage in HSCs could impair stem cell function by preventing replication and cell division, inducing apoptosis, or causing differentiation such that the HSCs can no longer self-renew. Rossi et al. measured self-renewal in vivo by quantifying donor LT-HSCs in the BM of transplanted mice. In mice transplanted with stem cells from aged XpdTTD, mTR−/− or Ku80−/− mice, the number of LT-HSCs was reduced 5, 16 and 26-fold, respectively, compared to mice transplanted with stem cells from wild type mice [13]. This inability to self-renew appears to be partly due to decreased proliferation of LT-HSCs. Growth of LT-HSCs derived from the progeroid mouse strains in vitro is significantly decreased compared to HSCs from wild type mice. In vivo, proliferation of HSCs and progenitors, measured by BrdU incorporation, is 2-fold greater in Lig4Y288C mice compared to age-matched controls [12]. Since BM cellularity and progenitor populations are significantly reduced in these mice, it implies that there must be a mechanism of cell loss. Indeed, LT-HSCs from DNA repair deficient mice are more prone to spontaneous apoptosis in vitro [13]. Thus loss of genome protection mechanisms leads to decreased HSC self-renewal either by preventing proliferation of the HSCs or promoting apoptosis of progeny cells.

Age-dependent accumulation of DNA damage causes loss of stem cell function

The best evidence that DNA damage is ultimately responsible for the loss of HSC function comes from the Lig4-deficient mice. That is because Lig4 functions exclusively in NHEJ repair of DSBs [18, 19]. Therefore, the hematopoietic phenotype of Lig4Y288C mice must be a direct consequence of failure to repair spontaneous DSBs. In accordance, γ-H2AX foci, a marker of DSBs [20] and replication stress [21] are significantly increased in HSCs isolated from Lig4-deficient mice compared to control littermates [12]. Furthermore, γ-H2AX foci are increased in HSCs isolated from old wild type mice compared to young [13]. Thus there is an in inverse correlation between DNA damage and HSC function.

This new data brings the number of mouse models with defective genome maintenance and reduced HSC function to ten (Table I). These include mice defective in six different mechanisms of genome maintenance, including NHEJ, nucleotide excision repair, homologous recombination-mediated DSB repair, interstrand crosslink repair, mismatch repair and telomere maintenance. Defects in any one of these mechanisms causes premature exhaustion of the BM as demonstrated by decreased ability to reconstitute the BM of an irradiated host in a competitive transplant assay (Table I). This inability to reconstitute BM becomes more pronounced with increased age of the donor and at late time points following transplantation (long-term reconstitution is more severely affected than short-term reconstitution), implicating loss of LT-HSC function as causal.

HSCs from mice defective in homologous recombination-mediated DSB repair are the most severely affected. Rad50 and ATM-deficient mice have frank BM failure (acellular marrow) by 8 and 24 wks of age, respectively [22, 23]. The BM of adult Brca2 and Lig4 mutant mice is hypocellular [12, 24]. Mice with defects in nucleotide excision repair, NHEJ repair of DSBs, DNA interstrand crosslink repair, mismatch repair or telomerase maintain normal BM cellularity into adulthood, suggesting a milder defect in HSC function. Interestingly mice expressing a hyperactive mutant allele of p53 that causes premature aging, also have impaired HSC function [25].

Model of how accumulated DNA damage impairs hematopoiesis

There is now overwhelming evidence that DNA damage limits stress-induced hematopoiesis. It does so by diminishing the ability of HSCs to proliferate and self-renew. It is worth emphasizing that this was demonstrated in DNA repair-deficient mice that were not exposed to exogenous genotoxic stress. Thus spontaneous or endogenous DNA damage is responsible for the loss of HSC function. Damage accumulation is not replication-dependent: DSBs accumulate in Lig4Y288C mouse embryonic fibroblasts cultured in stationary phase at physiological oxygen tension [12]. Therefore the genome of quiescent HSCs is susceptible to spontaneous DNA damage. In fact, more DNA damage is detected in HSCs than progenitor cells isolated from aged mice [13].

This could imply that progenitor cells are more prone to apoptosis or that they have a greater capacity for DNA repair relative to HSCs. In fact, there is reason to suspect both. Homologous recombination-mediated DSB repair requires a sister chromatid. Thus this repair pathway is restricted to S/G2 phases of the cell cycle [26] and limited to proliferating cells such as progenitors. Furthermore, quiescent stem cells have been demonstrated to be relatively resistant to apoptosis compared to progenitors [10, 27].

A key difference between progenitor cells and stem cells is their proliferation rate. The more rapidly dividing progenitors are preferentially lost in the absence of DNA repair, while quiescent stem cells persist and accumulate damage. This suggests that exit from G0 or entry into S phase of the cell cycle may be the point at which HSCs respond to a damaged genome. What is not clear is if HSCs with damaged genomes fail to enter S phase (replicative senescence) or initiate replication but undergo apoptosis. Regardless, the net result is that DNA damage accumulates in quiescent cells, while causing attrition of proliferating cells (Figure 2). Thus the BM of aged organisms is hypocellular, enriched for LT-HSCs and has diminished reconstituting capacity.

Figure 2
Model of how hematopoietic stem cell function is lost as a consequence of unrepaired DNA damage. A. The bone marrow of young mammals contains relatively rare, quiescent long term reconstituting hematopoietic stem cells (LT-HSCs), multi-potent progenitors ...

Implications for human aging

DNA repair deficient mice that mimic human syndromes are extremely valuable not only for understanding rare genetic diseases but also for discovering the health impact of endogenous DNA damage. The demonstration of impaired HSC function in XpdTTD, Ku80−/− and Lig4Y288C mice leads to the prediction that individuals with increased oxidative stress (e.g., Wilson’s disease) and cancer survivors treated with genotoxins are at risk of premature aging of the hematopoietic system. Similarly, the loss of HSC function in late generation mTr−/− mice leads to the prediction that hematopoietic stress, for instance caused by chronic inflammation or infection, may accelerate aging of the hematopoietic system.

The discovery that age-dependent accumulation of DNA damage limits stem cell function also warrants consideration when using adult stem cells for transplantation. Evidence that donor age affects outcome in BM transplantation is scant. In mice, there is increased skewing of engraftment towards myeloid lineages [28] and decreased immune reconstitution [29] if the donor is aged, consistent with impaired HSC function. In humans, donor age is inversely proportional to five year survival after BM transplantation, but primarily due to increased risk of graft versus host disease [30]. However, telomere length is greater in recipients transplanted with cells isolated from umbilical cord blood rather than adult blood, consistent with greater regenerative capacity of cells isolated from a young donor [31].

Although DNA repair deficient mice have decreased HSC function, the mice themselves don’t all become pancytopenic or symptomatic as a direct consequence of HSC exhaustion. So is the reduced HSC function observed in these model systems likely to impact the health or longevity of humans with normal DNA repair? There are several reasons to consider the possibility. First, BM cells from wild type mice competitively replace that of non-irradiated Lig4Y288C mice [12]. Thus even in the absence of stress-induced hematopoiesis, DNA damage accumulation leads to stem cell exhaustion. Second, in many cases, the phenotype of DNA repair deficient mice (Lig4Y288C, Csbm/m, XpdTTD, Xpa−/−) is milder than that of the human diseases they model (Ligase IV syndrome, Cockayne syndrome, trichothiodystrophy, xeroderma pigmentosum complementation group A, respectively) [12, 14, 32, 33]. For example, BM failure is a common feature in Ligase IV syndrome [34] and has been reported in xeroderma pigmentosum [35], unlike the mouse models, which do not become pancytopenic. This may indicate that mice incur less spontaneous DNA damage than humans, or that the environment is a major source of genotoxic stress [36] and the pristine conditions in which laboratory mice are kept is not a good model of humans. Cumulatively, these observations suggest that humans may be at greater risk of HSC exhaustion due to DNA damage accumulation than laboratory mice.

Acknowledgments

L.J.N. is supported by The Ellison Medical Foundation (AG-NS-0303-05) the NCI (CA111525 and CA10370) and the University of Pittsburgh Cancer Institute.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

1. D’Errico M, Lemma T, Calcagnile A, Proietti De Santis L, Dogliotti E. Cell type and DNA damage specific response of human skin cells to environmental agents. Mutat Res. 2007;614:37–47. [PubMed]
2. Nouspikel T. DNA repair in differentiated cells: some new answers to old questions. Neuroscience. 2007;145:1213–1221. [PubMed]
3. Bracker TU, Giebel B, Spanholtz J, Sorg UR, Klein-Hitpass L, Moritz T, Thomale J. Stringent regulation of DNA repair during human hematopoietic differentiation: a gene expression and functional analysis. Stem Cells. 2006;24:722–730. [PubMed]
4. Chen MF, Lin CT, Chen WC, Yang CT, Chen CC, Liao SK, Liu JM, Lu CH, Lee KD. The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Radiat Oncol Biol Phys. 2006;66:244–253. [PubMed]
5. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157–168. [PubMed]
6. Rossi DJ, Bryder D, Weissman IL. Hematopoietic stem cell aging: mechanism and consequence. Exp Gerontol. 2007;42:385–390. [PMC free article] [PubMed]
7. Kirkwood TB. Understanding the odd science of aging. Cell. 2005;120:437–447. [PubMed]
8. Schlessinger D, Van Zant G. Does functional depletion of stem cells drive aging? Mech Ageing Dev. 2001;122:1537–1553. [PubMed]
9. Van Zant G, Liang Y. The role of stem cells in aging. Exp Hematol. 2003;31:659–672. [PubMed]
10. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. [PubMed]
11. Barnes DJ, Melo JV. Primitive, quiescent and difficult to kill: the role of non- proliferating stem cells in chronic myeloid leukemia. Cell Cycle. 2006;5:2862–2866. [PubMed]
12. Nijnik A, Woodbine L, Marchetti C, Dawson S, Lambe T, Liu C, Rodrigues NP, Crockford TL, Cabuy E, Vindigni A, Enver T, Bell JI, Slijepcevic P, Goodnow CC, Jeggo PA, Cornall RJ. DNA repair is limiting for haematopoietic stem cells during ageing. Nature. 2007;447:686–690. [PubMed]
13. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature. 2007;447:725–729. [PubMed]
14. de Boer J, de Wit J, van Steeg H, Berg RJ, Morreau H, Visser P, Lehmann AR, Duran M, Hoeijmakers JH, Weeda GA. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol Cell. 1998;1:981–990. [PubMed]
15. Nussenzweig A, Chen C, da Costa Soares V, Sanchez M, Sokol K, Nussenzweig MC, Li GC. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 1996;382:551–555. [PubMed]
16. Ribes-Zamora A, Mihalek I, Lichtarge O, Bertuch AA. Distinct faces of the Ku heterodimer mediate DNA repair and telomeric functions. Nat Struct Mol Biol. 2007;14:301–307. [PubMed]
17. Blasco MA, Lee HW, Rizen M, Hanahan D, DePinho R, Greider CW. Mouse models for the study of telomerase. Ciba Found Symp. 1997;211:160–170. [PubMed]
18. Barnes DE, Stamp G, Rosewell I, Denzel A, Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr Biol. 1998;8:1395–1398. [PubMed]
19. Frank KM, Sharpless NE, Gao Y, Sekiguchi JM, Ferguson DO, Zhu C, Manis JP, Horner J, DePinho RA, Alt FW. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell. 2000;5:993–1002. [PubMed]
20. Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol. 1999;146:905–916. [PMC free article] [PubMed]
21. Rao VA, Conti C, Guirouilh-Barbat J, Nakamura A, Miao ZH, Davies SL, Sacca B, Hickson ID, Bensimon A, Pommier Y. Endogenous γ-H2AX-ATM- Chk2 Checkpoint Activation in Bloom’s Syndrome Helicase Deficient Cells Is Related to DNA Replication Arrested Forks. Mol Cancer Res. 2007;5:713–724. [PubMed]
22. Bender CF, Sikes ML, Sullivan R, Huye LE, Le Beau MM, Roth DB, Mirzoeva OK, Oltz EM, Petrini JH. Cancer predisposition and hematopoietic failure in Rad50(S/S) mice. Genes Dev. 2002;16:2237–2251. [PubMed]
23. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, Ikeda Y, Mak TW, Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004;431:997–1002. [PubMed]
24. Navarro S, Meza NW, Quintana-Bustamante O, Casado JA, Jacome A, McAllister K, Puerto S, Surralles J, Segovia JC, Bueren JA. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Mol Ther. 2006;14:525–535. [PubMed]
25. Dumble M, Moore L, Chambers SM, Geiger H, Van Zant G, Goodell MA, Donehower LA. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood. 2007;109:1736–1742. [PubMed]
26. Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A, Takeda S. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 1998;17:5497–5508. [PubMed]
27. Park Y, Gerson SL. DNA repair defects in stem cell function and aging. Annu Rev Med. 2005;56:495–508. [PubMed]
28. Liang Y, Van Zant G, Szilvassy SJ. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood. 2005;106:1479–1487. [PubMed]
29. Azuma E, Hirayama M, Yamamoto H, Komada Y. The role of donor age in naive T-cell recovery following allogeneic hematopoietic stem cell transplantation: the younger the better. Leuk Lymphoma. 2002;43:735–739. [PubMed]
30. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R, Ratanatharathorn V, Weisdorf D, Confer DL. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043–2051. [PubMed]
31. Pipes BL, Tsang T, Peng SX, Fiederlein R, Graham M, Harris DT. Telomere length changes after umbilical cord blood transplant. Transfusion. 2006;46:1038–1043. [PubMed]
32. van der Horst GT, van Steeg H, Berg RJ, van Gool AJ, de Wit J, Weeda G, Morreau H, Beems RB, van Kreijl CF, de Gruijl FR, Bootsma D, Hoeijmakers JH. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 1997;89:425–435. [PubMed]
33. de Vries A, van Oostrom CT, Hofhuis FM, Dortant PM, Berg RJ, de Gruijl FR, Wester PW, van Kreijl CF, Capel PJ, van Steeg H, et al. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature. 1995;377:169–173. [PubMed]
34. O’Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA, Concannon P. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell. 2001;8:1175–1185. [PubMed]
35. Salob SP, Webb DK, Atherton DJ. A child with xeroderma pigmentosum and bone marrow failure. Br J Dermatol. 1992;126:372–374. [PubMed]
36. Hoover RN. Cancer-nature, nurture, or both. N Engl J Med. 2000;343:135–136. [PubMed]
37. Carreau M, Gan OI, Liu L, Doedens M, Dick JE, Buchwald M. Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol. 1999;27:1667–1674. [PubMed]
38. Haneline LS, Gobbett TA, Ramani R, Carreau M, Buchwald M, Yoder MC, Clapp DW. Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood. 1999;94:1–8. [PubMed]
39. Reese JS, Liu L, Gerson SL. Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood. 2003;102:1626–1633. [PubMed]